转化医学在中国:五年回顾与展望

Review and prospect of translational medicine in China

近5年来,转化医学在中国完成了从理念到实践落地的转变,初步统计已建立了130多家各具特色的转化医学研究机构,重点关注重大疾病的临床与转化研究与合作.但同时也应当看到转化医学学科建设仍面临严峻的现实:一方面缺乏顶层的统筹规划和专项经费投入,以解决转化研究项目难以落实、研究资源与技术碎片化的问题;另一方面缺乏与国家科技战略发展相配合的激励机制和专业人才培养等.本文针对上述问题对"十三五"阶段我国转化医学领域的发展框架提出了初步建议.

During the past five years, translational medicine has completed the transformation from the concept to practice landed in China. A preliminary survey data has shown that more than 130 translational medicine research institutions or centers have been established in China, focusing on clinical and translational research in those major diseases areas. Meanwhile, the scientific disciplines of translational medicine are still facing the grim reality. On the one hand, the top level of design, the master plan and the dedicated research funds need to been strengthen, in order to achieve the transformation of clinical and translational projects and to resolve the problems of fragmentation on research resources and technology applications. On the other hand, the incentive mechanism and professional talent training in coordination with the national science and technology development strategy are still little paid attention. This article alms to suggest the translational medicine development framework of the Chinese＇s thirteen-five year national plan.